This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Johns Hopkins University. Active years: 1999-2021.
Company Filing History:
Years Active: 1999-2021
Title: The Innovative Contributions of Thomas August in Vaccine Development
Introduction
Thomas August, an accomplished inventor based in Baltimore, MD, has made significant strides in the field of vaccine development. With a total of 8 patents to his name, August's work focuses on enhancing immune responses through innovative chimeric proteins and nucleic acids. His inventions are particularly relevant in the context of targeted cancer treatments.
Latest Patents
One of Thomas August's latest patents involves the lysosomal targeting of antigens using nucleic acids that encode lysosomal membrane polypeptide/antigen chimeras. This groundbreaking invention offers valuable chimeric proteins and nucleic acids that can be utilized in creating vaccines for selected antigens. The chimeric protein is designed to include an antigen sequence along with a trafficking domain, which ensures the protein is directed to an endosomal compartment, regardless of whether the antigen originates from membrane or non-membrane proteins. Notably, the trafficking domain may consist of a lumenal domain of a LAMP polypeptide or a domain derived from an endocytic receptor, such as DEC-205 or gp200-MR6. The vaccines produced—be they DNA, RNA, or protein—are capable of modulating or enhancing immune responses against various antigens. Importantly, this invention also outlines a method to treat patients with cancer by administering a chimeric protein comprised of cancer-specific antigens.
Career Highlights
Thomas August's career is marked by his commitment to advancing vaccine technologies and cancer therapies. His patents reflect a blend of innovative ideas and practical applications in the medical field. Working at The Johns Hopkins University, August leverages the institution’s resources and collaborative environment to focus on critical innovations that address significant health challenges.
Collaborations
Throughout his career, August has collaborated with notable colleagues such as Ernesto Marques, Jr. and Vu L Truong. These partnerships strengthen his research efforts and contribute to the breakthroughs he has achieved in vaccine technology.
Conclusion
In summary, Thomas August is an exemplary inventor whose impactful work in vaccine development positions him as a leader in the fight against diseases like cancer. His innovative patents and collaborations at The Johns Hopkins University highlight his dedication to improving patient outcomes through scientific advancement. As he continues to forge new paths in medical research, the implications of his work are likely to resonate within the scientific community and beyond.